Inventor
DEURER LOTHAR
DE15 patents
⚠️ This page may combine multiple inventors who share the name “DEURER LOTHAR”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
LOHMANN THERAPIE SYST LTS
12 patentsUS5240711AAug 31, 1993
Transdermal therapeutic system comprising as active component buprenorphine
LOHMANN THERAPIE SYST LTS169 citations99
US6814976B1Nov 9, 2004
Transdermal therapeutic system comprising a reservoir-type pressure-sensitive adhesive layer and a back layer with uni-directional resilience
LOHMANN THERAPIE SYST LTS44 citations96
US5700480ADec 23, 1997
Transdermal therapeutic system comprising galanthamine as active component
LOHMANN THERAPIE SYST LTS94 citations96
US7384651B2Jun 10, 2008
Transdermal therapeutic system comprising a reservoir type pressure sensitive adhesive layer and a back layer with uni-directional resilience
LOHMANN THERAPIE SYST LTS37 citations92
US6315854B1Nov 13, 2001
Transdermal therapeutic plaster
LOHMANN THERAPIE SYST LTS21 citations89
US7824707B2Nov 2, 2010
Transdermal therapeutic system provided with improved long-term carrying comfort
LOHMANN THERAPIE SYST LTS10 citations84
US5891290AApr 6, 1999
Method for the transfer of sections that are self-adhesive on one side from a moving first web onto a moving second web
LOHMANN THERAPIE SYST LTS17 citations83
US6558696B1May 6, 2003
Desoxypeganine
LOHMANN THERAPIE SYST LTS10 citations74
US5681413AOct 28, 1997
Production of transdermal therapeutic systems
LOHMANN THERAPIE SYST LTS15 citations72
US5869086AFeb 9, 1999
Systems for the controlled release of pilocarpine
LOHMANN THERAPIE SYST LTS11 citations71
US5698216ADec 16, 1997
Transdermal therapeutic system for the administration of physostigmine to the skin and process for the production thereof
LOHMANN THERAPIE SYST LTS2 citations59
US9101605B2Aug 11, 2015
Buprenorphine transdermal therapeutic system and method of administering
LOHMANN THERAPIE SYST LTS0 citations52